Edition:
United States

Business

AbbVie to buy Botox-maker Allergan in $63 billion deal

Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.

Business Video

Markets

S&P » 2,945.35 +0.00%
Dow » 26,727.54 +0.03%
FTSE 100 » 7,409.38 -0.10%
Nikkei 225 » 21,193.81 -0.43%
US 10YR
+2.019
+0.000
DE 10YR
-0.318
-0.010
JP 10YR
-0.148
+0.006
USD / EUR » 0.8784 +0.14%
USD / GBP » 0.7855 +0.10%
USD / JPY » 107.0800 -0.19%